Literature DB >> 25708046

Viral hepatitis: Scaling up HCV treatment in resource-limited countries.

Maud Lemoine1, Mark Thursz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25708046     DOI： 10.1038/nrgastro.2015.31

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  8 in total

1.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Authors:  Joseph F Perz; Gregory L Armstrong; Leigh A Farrington; Yvan J F Hutin; Beth P Bell
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

Review 2.  Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach.

Authors:  Maud Lemoine; Serge Eholié; Karine Lacombe
Journal:  J Hepatol       Date:  2014-10-16       Impact factor: 25.083

3.  How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.

Authors:  Dorothée Obach; Yazdan Yazdanpanah; Gamal Esmat; Anchalee Avihingsanon; Sahar Dewedar; Nicolas Durier; Alain Attia; Wagida A Anwar; Anthony Cousien; Pisit Tangkijvanich; Serge Paul Eholié; Wahid Doss; Aya Mostafa; Arnaud Fontanet; Mostafa K Mohamed; Sylvie Deuffic-Burban
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

Review 4.  Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas.

Authors:  Maud Lemoine; Mark Thursz
Journal:  Semin Liver Dis       Date:  2014-04-29       Impact factor: 6.115

5.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

Review 6.  Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.

Authors:  Khayriyyah Mohd Hanafiah; Justina Groeger; Abraham D Flaxman; Steven T Wiersma
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

Review 7.  Cure of hepatitis C virus infection without interferon alfa: scientific basis and current clinical evidence.

Authors:  David L Thomas
Journal:  Top Antivir Med       Date:  2014-01

8.  Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.

Authors:  Andrew Hill; Saye Khoo; Joe Fortunak; Bryony Simmons; Nathan Ford
Journal:  Clin Infect Dis       Date:  2014-01-06       Impact factor: 9.079
  8 in total
  3 in total

1.  HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.

Authors:  Léa Duchesne; Richard Njouom; Frédéric Lissock; Gishlaine Flore Tamko-Mella; Sandrine Rallier; Lila Poiteau; Alexandre Soulier; Stéphane Chevaliez; Guy Vernet; Nicolas Rouveau; Jean-Michel Pawlotsky; Pierre-Marie Girard; Karine Lacombe
Journal:  J Int AIDS Soc       Date:  2017-05-15       Impact factor: 5.396

2.  Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania.

Authors:  Zameer Mohamed; Jessie Mbwambo; Yusuke Shimakawa; Lila Poiteau; Stéphane Chevaliez; Jean-Michel Pawlotsky; John Rwegasha; Sanjay Bhagani; Simon D Taylor-Robinson; Julie Makani; Mark R Thursz; Maud Lemoine
Journal:  J Int AIDS Soc       Date:  2017-09-19       Impact factor: 5.396

3.  Breaking Down Barriers to Care in Hepatitis C Virus Infection.

Authors:  Mark Thursz; Karine Lacombe
Journal:  J Infect Dis       Date:  2015-09-02       Impact factor: 5.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.